VolitionRX's market cap is currently ―. The company's EPS TTM is $-0.501; its P/E ratio is -1.48; VolitionRX is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 165.21K	$ 216.31K	$ 149.81K	$ 119.72K	$ 32.71K
Gross Profit	$ 165.21K	$ 216.31K	$ 149.81K	$ 119.72K	-
EBIT	$ -8.40M	$ -9.49M	$ -8.88M	$ -7.35M	$ -7.77M
EBITDA	$ -8.04M	$ -9.14M	$ -9.15M	$ -8.06M	$ -7.48M
Net Income Common Stockholders	$ -8.45M	$ -9.55M	$ -8.78M	$ 8.04M	$ -7.74M
Balance Sheet	-
Cash Cash Equivalents And Short Term Investments	$ 10.81M	$ 19.74M	$ 10.01M	$ 10.87M	$ 16.42M
Total Assets	$ 18.04M	$ 27.56M	$ 18.04M	$ 18.30M	$ 23.34M
Total Debt	$ 4.30M	$ 4.68M	$ 4.77M	$ 4.97M	$ 4.47M
Net Debt	$ -6.50M	$ -15.07M	$ -5.24M	$ -5.89M	$ -11.94M
Total Liabilities	$ 20.89M	$ 22.44M	$ 21.02M	$ 21.42M	$ 20.50M
Stockholders Equity	$ -2.04M	$ 5.84M	$ -2.34M	$ -3.13M	$ 3.30M
Cash Flow	-
Free Cash Flow	$ -8.69M	$ -7.65M	$ -8.95M	$ -5.76M	$ -7.14M
Operating Cash Flow	$ -8.42M	$ -7.35M	$ -8.74M	$ -5.18M	$ -6.82M
Investing Cash Flow	$ -273.04K	$ -301.39K	$ -200.59K	$ -578.75K	$ -325.49K
Financing Cash Flow	$ -274.76K	$ 17.34M	$ 8.15M	$ 305.42K	$ 6.73M

Currency in USD

VolitionRX Earnings and Revenue History

Income Statement >

VolitionRX Debt to Assets

Balance Sheet >

VolitionRX Cash Flow

Cash Flow >

VolitionRX Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing